Bullish
Alpha Cognition enrolls first patient in ZUNVEYL phase 4 study By Investing.com
Alpha Cognition Inc. has enrolled the first patient in its Phase 4 clinical study, RESOLVE, for ZUNVEYL, an FDA-approved treatment for mild to moderat...